身体组成参数对局部晚期直肠癌放射治疗依从性的影响:一项回顾性观察分析
该回顾性单中心研究纳入2010至2020年628例局部晚期直肠癌患者,利用治疗前模拟CT进行身体组成分析。结果显示较高BMI(OR 2.38,95%CI 1.36-4.01)和较低骨骼肌指数(0.73,95%CI 0.55-0.94)是放疗中断的独立预测因素;肌少性肥胖(HR 2.83,95%CI 1.24-6.45)与较差总生存相关,较高内脏脂肪组织与较差无病生存相关(1.02,95%CI 1.01-1.03),较高骨骼肌指数与更好局部控制相关(0.96,95%CI 0.93-0.99)。作者认为身体组成分析可能有助于局部晚期直肠癌放疗患者的管理。
要点
- 较高BMI(OR 2.38,95%CI 1.36-4.01)和较低骨骼肌指数(0.73,95%CI 0.55-0.94)是放疗中断的独立预测因素。
- 肌少性肥胖与较差总生存相关(HR 2.83,95%CI 1.24-6.45)。
- 较高内脏脂肪组织与较差无病生存相关(1.02,95%CI 1.01-1.03),较高骨骼肌指数与更好局部控制相关(0.96,95%CI 0.93-0.99)。
核心结论
- 身体组成分析,特别是肌肉和脂肪质量的分析,可能成为改善局部晚期直肠癌放疗患者管理的有用工具。
- 作者建议放射肿瘤科医生与临床营养师加强合作,以便对局部晚期直肠癌患者实现早期营养支持。
研究设计与样本
- 这是一项回顾性单中心研究,纳入2010年至2020年间治疗的局部晚期直肠癌患者。
- 使用治疗前模拟CT扫描的单个层面,通过专用软件进行身体组成分析。
- 主要终点为身体组成对放疗中断的影响,次要终点为总生存、无病生存和局部控制。
- 研究共纳入628例局部晚期直肠癌患者(女性占40.9%,平均年龄63.4岁)。
主要发现
- 24%的患者骨骼肌指数低,30%的患者肌肉密度低,17例(占肥胖者的10.3%)为肌少性肥胖。
- 较高BMI(OR 2.38,95%CI 1.36-4.01)和较低骨骼肌指数(0.73,95%CI 0.55-0.94)是放疗中断的独立预测因素。
- 肌少性肥胖(HR 2.83,95%CI 1.24-6.45)与较差总生存相关。
- 肌肉密度(0.96,95%CI 0.93-0.98)和较高骨骼肌指数(0.97,95%CI 0.95-0.99)与较好总生存相关;较低肌肉密度在调整多变量分析中仍保持关联(0.96,95%CI 0.93-0.98)。
- 较高内脏脂肪组织与较差无病生存相关(1.02,95%CI 1.01-1.03),较高骨骼肌指数与更好局部控制相关(0.96,95%CI 0.93-0.99)。
临床怎么用
- 作者认为身体组成分析可能有助于局部晚期直肠癌放疗患者的更好管理。
- 作者建议放射肿瘤科医生与临床营养师加强合作,以便对局部晚期直肠癌患者实现早期营养支持。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The impact of body composition and sarcopenia in locally advanced rectal cancer (LARC) is still unclear, even several studies have been published on this issue. Our study aims to analyze the impact of sarcopenia on neoadjuvant chemoradiotherapy (nCRT) tolerance and survival outcomes. METHODS: This is a retrospective, monocentric study where LARC patients treated between 2010 and 2020 were enrolled. A single slice, from the pre-therapy simulation computed tomography (CT) scan, was used to perform the body composition analysis with dedicated software. The primary endpoint was the impact of body composition on radiotherapy (RT) interruption secondarily on overall survival (OS), disease-free survival (DFS), and local control (LC). RESULTS: The study included 628 LARC patients (40.9 % female, mean age 63.4 years): 24 % had low skeletal muscle index (SMI), 30 % had low muscle density (MD) and 17 (10.3 % of obese) were sarcopenic obese. Higher BMI (OR 2.38, 95 % CI 1.36-4.01) and lower SMI (0.73, 95 % CI 0.55-0.94) resulted as independent predictors of RT interruption. Sarcopenic obesity (HR 2.83, 95 % CI 1.24-6.45) was related to worse OS, while MD (0.96, 95 % CI 0.93-0.98), and higher SMI (0.97, 95 % CI 0.95-0.99) were related to better OS; a lower MD remained also associated even in adjusted multivariable analysis (0.96, 95 % CI0.93-0.98). Moreover, higher visceral adipose tissue (VAT) resulted associated with worse DFS (1.02, 95 % CI 1.01-1.03), while higher SMI was related to better Local Control (0.96, 95 % CI 0.93-0.99). CONCLUSIONS: Body composition analysis, particularly of muscle and fat masses, may be a useful tool for better management of LARC patients undergoing RT. Increased collaboration between radiation oncologists and clinical nutritionists is advisable, to enable early nutritional support of LARC.
引用
- Chiloiro G, Cintoni M, Palombaro M, et al. Impact of body composition parameters on radiation therapy compliance in locally advanced rectal cancer: A retrospective observational analysis. Clin Transl Radiat Oncol. 2024. PMID: 38741926. doi:10.1016/j.ctro.2024.100789
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。